Physician profile
Nancy Witcher
NPI 1255320875
$1,148.57
in general payments reported to CMS, 2019-2025
22 companies · $87.99 in 2025
The $87.99 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $287 · 2023: $305 · 2024: $247 · 2025: $87.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $202.06 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $158.18 | 2022-2024 | Jornay Pm |
| Pfizer INC. | $97.59 | 2021-2024 | |
| Alk-Abello, INC | $88.46 | 2023-2024 | Ragwitek, Grastek, Odactra |
| Merck Sharp & Dohme LLC | $72.75 | 2022-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $71.99 | 2022-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $56.29 | 2021-2022 | |
| Neos Therapeutics, Lp | $55.96 | 2021-2024 | Adzenys Xr-Odt |
| Sanofi Pasteur INC. | $44.05 | 2021-2023 | |
| Seqirus USA INC | $39.85 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Neurelis, INC. | $36.62 | 2022-2023 | Valtoco |
| Glaxosmithkline, LLC. | $26.84 | 2023 | Bexsero |
| Tris Pharma INC | $26.12 | 2022-2025 | Dyanavel Xr |
| Sobi, INC | $25.23 | 2022-2023 | |
| Novo Nordisk INC | $24.02 | 2025 | Wegovy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $22.81 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.84 | 2023 | Flumist Quadrivalent |
| Adlon Therapeutics L.P. | $20.46 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.82 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.96 | 2025 | Jornay Pm |
| Abbvie INC. | $14.51 | 2025 | |
| Amgen INC. | $13.16 | 2024 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Witcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.